New York Attorney General Letitia James office is demanding that a Manhattan hospital resume the provision of puberty-blocking drugs and cross-sex hormones to gender dysphoric adolescents, which the ...

The state orders NYU Langone to resume transgender youth health services, including puberty blockers and hormone therapies for patients under 19.

The health official behind the pause of the NHS’s puberty blocker trial is blocked from any further involvement amid accusations of bias.

Regulator says Prof Jacob George will no longer be involved after gender-criticial social media posts from last year ...

The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.

A UK clinical trial aiming to assess the effect of puberty blockers on young people with gender incongruence continues to be mired in controversy. Just a week after the trial was paused by the ...

Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14 ...

Puberty blockers are among the most-misunderstood – and most-targeted – form of gender-affirming care, and that’s no coincidence. Often referred to as hormone suppressants, they are a form of ...

The controversial Pathways trial assessing the effect of puberty blockers on young people with gender incongruence has been paused owing to “concerns related to the wellbeing of participants.” The UK ...

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week ...

There will come a day when I don’t have to try to persuade anyone that medicalising and sterilising children is not a good idea. There will come a day when professional people do not lose their jobs ...

Australia’s medicine safety officials have warned the government they are flying blind on the use of puberty blocker drugs ...